Found: 14
Select item for more details and to access through your institution.
Noninvasive minimal residual disease assessment in relapsed/refractory large B‐cell lymphoma using digital droplet PCR.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 6, p. 957, doi. 10.1111/ejh.14191
- By:
- Publication type:
- Article
JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO).
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 728, doi. 10.1111/ejh.13859
- By:
- Publication type:
- Article
Impact of timing and precision of histopathological diagnosis on outcomes of patients with Burkitt lymphoma and high‐grade B‐cell lymphoma.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 5, p. 403, doi. 10.1111/ejh.13747
- By:
- Publication type:
- Article
Treatment patterns and disease course of previously untreated Primary Central Nervous System Lymphoma: Feasibility of MTX‐based regimens in clinical routine.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 2, p. 202, doi. 10.1111/ejh.13639
- By:
- Publication type:
- Article
Fatal disseminated enterovirus infection in a patient with follicular lymphoma undergoing obinutuzumab maintenance therapy.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 3, p. 268, doi. 10.1111/ejh.13278
- By:
- Publication type:
- Article
Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Health Claims Data Analysis.
- Published in:
- Oncology & Therapy, 2023, v. 11, n. 1, p. 65, doi. 10.1007/s40487-022-00211-6
- By:
- Publication type:
- Article
Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. e498, doi. 10.1016/j.clml.2022.01.007
- By:
- Publication type:
- Article
Survival outcomes of patients newly diagnosed with diffuse large B-cell lymphoma: real-world evidence from a German claims database.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7091, doi. 10.1007/s00432-023-04660-y
- By:
- Publication type:
- Article
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1361, doi. 10.1007/s00259-023-06554-0
- By:
- Publication type:
- Article
Specialized palliative care in patients with haematological malignancies receiving chimeric antigen receptor T‐cell therapy.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 1, p. 343, doi. 10.1111/bjh.19434
- By:
- Publication type:
- Article
Reinduction therapy with everolimus in combination with dexamethasone, high‐dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD‐R3i)
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 606, doi. 10.1111/bjh.17878
- By:
- Publication type:
- Article
Teamspezifische Auswirkungen der Corona-Pandemie auf Mitarbeiter:innen der Internistischen Intensivmedizin eines Krankenhauses der Maximalversorgung.
- Published in:
- Medizinische Klinik: Intensivmedizin & Notfallmedizin, 2023, v. 118, n. 7, p. 556, doi. 10.1007/s00063-022-00959-9
- By:
- Publication type:
- Article
Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 1, p. 191, doi. 10.1007/s00277-022-05028-x
- By:
- Publication type:
- Article
Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes—results of a retrospective analysis from a German university hospital.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 2, p. 389, doi. 10.1007/s00277-021-04698-3
- By:
- Publication type:
- Article